GlaxoSmithKline Tests RFID on HIV Drug

In a pilot project involving the HIV medication Trizivir, the company is testing its ability to commission and later read RFID tags, which could be used to verify the drug's authenticity.

Email To A Friend

TOPICS

ARTICLES

PREMIUM CONTENT

EVENTS

COMMUNITY

TOOLS & RESOURCES

INDUSTRIES

Site design: Loewy Design

GlaxoSmithKline Tests RFID on HIV Drug

Email To A Friend

sending it your way

RSS Content Feeds

Sign up for one of our E-Newsletters.

take the poll

RFID EVENTS

RFID BUYER’S GUIDE

Ask the Experts

	E-mail me periodic updates from RFID Journal, including Information about Web site enhancements, events, training and other products.
	E-mail me periodic information and offers from select RFID Journal partners.